Coronavirus Spectrum Infections (COVID-19, MERS, SARS) in Cancer Patients: A Systematic Review of the Literature

References

• Mahase E. COVID-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020;368:m1036.
   PubMedGoogle Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323:1239. doi:10.1001/jama.2020.2648.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/NEJMoa2002032.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al.; for the COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi:10.1001/jama.2020.5394.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547. doi:10.1183/13993003.01227-2020.
   PubMed Web of Science ®Google Scholar
• Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10:589–597. doi:10.1016/S1470-2045(09)70069-5.
   PubMed Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337. doi:10.1016/S1470-2045(20)30096-6.
   PubMed Web of Science ®Google Scholar
• Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130–137. doi:10.1111/resp.13196.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W-65–W-94. doi:10.7326/0003-4819-151-4-200908180-00136.
   Web of Science ®Google Scholar
• Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23:60–63. doi:10.1136/bmjebm-2017-110853.
   PubMedGoogle Scholar
• Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–704. doi:10.1016/j.jtho.2020.02.010.
   PubMed Web of Science ®Google Scholar
• Yu J, Ouyang W, Chua ML, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;6:1108. doi:10.1001/jamaoncol.2020.0980.
   PubMed Web of Science ®Google Scholar
• Cai Y, Hao Z, Gao Y, Ping W, Wang Q, Peng S, et al. COVID-19 in the perioperative period of lung resection: a brief report from a single thoracic surgery department in Wuhan, China. J Thorac Oncol. 2020;15:1065–1072. doi:10.1016/j.jtho.2020.04.003.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Qin J, Wang H, Qin X, et al. Perioperative presentation of COVID-19 disease in a liver transplant recipient. Hepatology. 2020. doi:10.1002/hep.31257.
   Web of Science ®Google Scholar
• Zhang H, Huang Y, Xie C. The treatment and outcome of a lung cancer patient infected with SARS-CoV-2. J Thorac Oncol. 2020;15:e63–e64. doi:10.1016/j.jtho.2020.02.025.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. Ann Oncol. 2020;31:894–901. doi:10.1016/j.annonc.2020.03.296.
   PubMed Web of Science ®Google Scholar
• Zhang X, Song K, Tong F, Fei M, Guo H, Lu Z, et al. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. Blood Adv. 2020;4:1307–1310. doi:10.1182/bloodadvances.2020001907.
   PubMed Web of Science ®Google Scholar
• Bonomi L, Ghilardi L, Arnoldi E, Tondini CA, Bettini AA. Rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab. J Thorac Oncol. 2020;15:e83–e85. doi:10.1016/j.jtho.2020.03.021.
   PubMed Web of Science ®Google Scholar
• Spezzani V, Piunno A, Iselin HU. Benign COVID-19 in an immunocompromised cancer patient-the case of a married couple. Swiss Med Wkly. 2020;150:w20246.
   PubMed Web of Science ®Google Scholar
• Alaskar A, Bosaeed M, Rehan H, Mendoza MA, Alahmari B, Othman A, et al. Middle east respiratory syndrome (MERS) infection in hematological and oncological patients: a case series from a tertiary care center in Saudi Arabia. Blood. 2019;134:5871. doi:10.1182/blood-2019-123253.
   Web of Science ®Google Scholar
• Fagbo S, Hakawi AM, Mukahal M, Skakni L, Santos A, Garbati M, et al. Atypical presentation and nosocomial spread-intensifying the MERS mystery and misery. Int J Infect Dis. 2016;45:209. doi:10.1016/j.ijid.2016.02.477.
   Web of Science ®Google Scholar
• Jazieh AR, Alenazi TH, Alhejazi A, Al Safi F, Al Olayan A. Outcome of oncology patients infected with coronavirus. JCO Glob Oncol. 2020;6:471–475. doi:10.1200/GO.20.00064.
   PubMedGoogle Scholar
• Motabi IH, Zaidi SZA, Ibrahim MH, Tailor IK, Alshehry NF, AlGhamdi MS, et al. Report of middle east respiratory syndrome coronavirus (MERSCoV) infection in four patients with hematological malignancies treated at king fahad medical City, Riyadh, Saudi Arabia. Blood. 2016;128:4903–4903. doi:10.1182/blood.V128.22.4903.4903.
   Web of Science ®Google Scholar
• Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013;13:745–751. doi:10.1016/S1473-3099(13)70154-3.
   PubMed Web of Science ®Google Scholar
• Kim SH, Ko JH, Park GE, Cho SY, Ha YE, Kang JM, et al. Atypical presentations of MERS-CoV infection in immunocompromised hosts. J Infect Chemother. 2017;23:769–773. doi:10.1016/j.jiac.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Lam MF, Ooi GC, Lam B, Ho JC, Seto WH, Ho PL, et al. An indolent case of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2004;169:125–128. doi:10.1164/rccm.200306-754CR.
   PubMed Web of Science ®Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323:1775–1776.
   PubMed Web of Science ®Google Scholar
• Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in. N Engl J Med. 2020;382:2372–2374. doi:10.1056/NEJMc2010419.
   PubMed Web of Science ®Google Scholar
• ACS. COVID-19 guidelines for triage of cancer surgery patients. [accessed 2020 Apr 24]. Available from: https://www.facs.org/covid-19/clinical-guidance/elective-case/cancer-surgery
   Google Scholar
• ASCO. COVID-19 patient care information. 2020 [accessed 2020 Apr 16]. Available from: https://www.asco.org/asco-coronavirus-information/care-individuals-cancer-during-covid-19
   Google Scholar
• ASTRO. COVID-19 recommendations to radiation oncology practices. [accessed 2020 Apr 24]. Available from: https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-Information
   Google Scholar
• Schrag D, Hershman DL, Basch E. Oncology practice during the COVID-19 pandemic. JAMA. 2020;323:2005. doi:10.1001/jama.2020.6236.
   PubMed Web of Science ®Google Scholar
• Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;2:100107. doi:10.1016/j.ajogmf.2020.100107.
   PubMed Web of Science ®Google Scholar
• Barry M, Al Amri M, Memish ZA. COVID-19 in the shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health. 2020;10:1–3. doi:10.2991/jegh.k.200218.003.
   PubMed Web of Science ®Google Scholar
• Cannistra SA, Haffty BG, Ballman K. Challenges faced by medical journals during the COVID-19 pandemic. JCO. 2020;38:2206–2207. doi:10.1200/JCO.20.00858.
   PubMed Web of Science ®Google Scholar
• Luo J, Rizvi H, Egger JV, Preeshagul IR, Wolchok JD, Hellmann MD. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers. Cancer Discov. 2020;10:1121–1128. doi:10.1158/2159-8290.CD-20-0596.
   PubMed Web of Science ®Google Scholar
• Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10:935–941. doi:10.1158/2159-8290.CD-20-0516.
   PubMed Web of Science ®Google Scholar
• Desai A, Warner JL, Kuderer NM, et al. The blind leading the blind: COVID-19, cancer, and the need for more data. [accessed 2020 Apr 26]. Available from: https://www.ascopost.com/issues/april-25-2020/covid-19-cancer-and-the-need-for-more-data/
   Google Scholar